Cost-minimisation analysis versus cost-effectiveness analysis, revisited.
We aim to establish whether it is ever appropriate to conduct cost-minimisation analysis (CMA) rather than cost-effectiveness analysis.We perform a literature review to examine how the use of CMA has changed since Briggs and O'Brien announced its death in 2001. Examples of simulated and trial d...
Egile Nagusiak: | Dakin, H, Wordsworth, S |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2013
|
Antzeko izenburuak
-
Cost-minimisation analysis versus cost-effectiveness analysis, revisited
nork: Dakin, H, et al.
Argitaratua: (2013) -
Cost-minimisation analysis versus cost-effectiveness analysis, revisited
nork: Dakin, H, et al.
Argitaratua: (2011) -
Cost-minimisation analysis of plasma exchange versus IVIg in the treatment of autoimmune neurological conditions
nork: Tara Klemencic Kozul, et al.
Argitaratua: (2022-07-01) -
A cost minimisation analysis in teledermatology: model-based approach
nork: Eminović Nina, et al.
Argitaratua: (2010-08-01) -
A cost minimisation analysis of a telepaediatric otolaryngology service
nork: Wootton Richard, et al.
Argitaratua: (2008-02-01)